Loading provider…
Loading provider…
Ophthalmology Physician in Sacramento, CA
NPI: 1063619674Primary Practice Location
UNIVERSITY OF CALIFORNIA DAVIS MEDICAL CENTER
4301 X St, Sacramento, CA
Primary Employer
UC Davis Medical Group
health.ucdavis.edu
HQ Phone
Get MD PHD Ala's Phone Numberphone_androidMobile
Get MD PHD Ala's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
CA State Medical License
2012 - 2025
MD State Medical License
2010 - 2015

American Board of Ophthalmology
Ophthalmology
University Of Washington School Of Medicine
uwmedicine.washington.edu
Medical School
Until 2006
Johns Hopkins University
Residency • Ophthalmology
2007 - 2010
University of Texas Health Science Center at Houston
Internship • Transitional Year
2006 - 2007
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 92134Diagnostic imaging of retina | 350 | 846 |
| 2 | 92014Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | 154 | 179 |
| 3 | 67028Injection of drug into eye | 101 | 445 |
| 4 | 99214Established patient office or other outpatient visit, 30-39 minutes | 90 | 140 |
| 5 | 99213Established patient office or other outpatient visit, typically 15 minutes | 90 | 106 |
Authors: Salpeter, Elyse M, Moshiri, Ala, Ferneding, Michelle, Motta, Monica J, Park, Sangwan, Skouritakis, Chrisoula, Thomasy, Sara M
Journal: Transl Vis Sci Technol
Intraoperative Retinal Changes May Predict Surgical Outcomes After Epiretinal Membrane Peeling.
Authors: Jordan Storkersen, Parisa Emami Naeini, Amirfarbod Yazdanyar, Glenn Yiu, Susanna Park
Journal: Transl Vis Sci Technol
Lead Sponsor: University of California, Davis
Collaborators: Cures Within Reach, The Retina Society
Intervention / Treatment: BIOLOGICAL: Intravitreal autologous CD34+ cells
Lead Sponsor: ThromboGenics